We Evaluated Adult Patients with Long-standing Psoriasis for Depression and Anxiety to Evaluate the Mental Effects of Psoriasis and Its effect on the Quality of Life.
Not Applicable
- Conditions
- Health Condition 1: L409- Psoriasis, unspecified
- Registration Number
- CTRI/2021/04/032731
- Lead Sponsor
- Belagavi Institute of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Diagnosis of psoriasis for at least 12 months
Exclusion Criteria
- Congenital illness
- Psychiatric illness
- Endocrine illness
- Cardiovascular illness
- Neurological illness
- Rheumatological illness
- Malignancies
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate the prevalence of anxiety and depression in adult patients with chronic psoriasis and evaluate the correlation between the severity of psoriasis and severity of anxiety and depressionTimepoint: Single visit
- Secondary Outcome Measures
Name Time Method Assess the relationship between DLQI and parameters of psoriasis.Timepoint: Single visit;To assess the relationship between clinical variables of psoriasis, drug history for psoriasis, and severity of anxiety and depression.Timepoint: Single visit